Covid19, Vaccines (DBCOND0137979)

Identifiers

Synonyms
COVID-19 Vaccine / COVID-19 Vaccines / COVID 19 Vaccine / Covid19 Vaccine / COVID19 Vaccines / Vaccine product against severe acute respiratory syndrome coronavirus 2 (medicinal product)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06597370
Immunogenicity Induced by COVID-19 Vaccines in Mexican PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT04963790
Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine UptakeNo drug interventionspreventionNot Availableterminated
NCT05097053
A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19prevention4unknown_status
NCT04691947
Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VACNo drug interventionsprevention1completed
NCT05542693
Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccineprevention2unknown_status
NCT05774171
To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2No drug interventionsNot AvailableNot Availablerecruiting
NCT05822219
Vaccine Hesitancy in Black/African Americans With Rheumatic DiseasesNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05463419
A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.No drug interventionsprevention2 / 3completed
NCT04546841
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adultsprevention1completed
NCT05998824
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT05198596
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Aboveprevention3completed
NCT04566276
ChulaCov19 Vaccine in Healthy AdultsNo drug interventionsother1 / 2completed
NCT04884776
Modulation of Gut Microbiota to Enhance Health and ImmunityNo drug interventionspreventionNot Availableactive_not_recruiting
NCT04838080
Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to PlaceboNo drug interventionsprevention1unknown_status
NCT04784689
Host Immune Response to Novel RNA COVID-19 VaccinationNo drug interventionsNot AvailableNot Availablecompleted
NCT05004740
Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1cNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05216601
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19prevention1completed
NCT05752201
ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) VaccineNo drug interventionsprevention2 / 3completed
NCT05197712
Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 DiseaseNo drug interventionsprevention1active_not_recruiting
NCT04751695
Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 VaccinesNo drug interventionsscreeningNot Availableunknown_status
NCT05656508
ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) VaccineNo drug interventionsprevention1completed
NCT05426343
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222prevention3completed
NCT04751721
Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 VaccinesNo drug interventionsscreeningNot Availableunknown_status
NCT05268679
Covid-19 Vaccine Response in Heart Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05197153
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19prevention2completed
NCT05455983
COVID-19 Vaccine and Development of Immune Thrombocytopenic PurpuraNo drug interventionsNot AvailableNot Availableunknown_status
NCT04910971
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 YearNo drug interventionsNot AvailableNot Availableunknown_status
NCT06167915
Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine (CHO Cell)LYB002V14 in Booster VaccinationNo drug interventionsprevention1not_yet_recruiting
NCT05142332
PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXEDNo drug interventionshealth_services_researchNot Availableterminated
NCT05012800
Safety and Immunogenicity of COVID-19 Vaccine Administered in Older AdultsNo drug interventionsprevention4unknown_status
NCT04830800
A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVACNo drug interventionsprevention1 / 2completed
NCT05312619
The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort SurveyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04764422
Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in ThailandNo drug interventionsprevention1 / 2completed
NCT04988048
Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentinaprevention2unknown_status
NCT05049226
Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccineprevention2completed
NCT05873374
Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19No drug interventionsprevention2not_yet_recruiting
NCT04915820
Iron and COVID-19 Vaccine ResponseNo drug interventionsbasic_scienceNot Availablecompleted
NCT05288231
Cardiac Manifestation in Adolescent After Pfizer COVID-19 Injection in ThailandNo drug interventionsNot AvailableNot Availablecompleted
NCT05348629
Efficacy and Safety of Covid-19 Vaccine in Cardiac PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05175989
SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19No drug interventionsNot AvailableNot Availableunknown_status
NCT05869968
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCINo drug interventionsNot AvailableNot Availablerecruiting
NCT05188469
Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult VolunteersNo drug interventionsprevention1 / 2active_not_recruiting
NCT04898946
Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong KongNot AvailableNot Availablecompleted
NCT05293223
Phase IIB Study of Recombinant Novel Coronavirus Vaccineprevention2active_not_recruiting
NCT05553743
Researchers at UC San Diego Are Learning About the Benefits of Human Milk and How it Influences Infant and Child HealthNo drug interventionsNot AvailableNot Availablerecruiting
NCT04800965
Text-based Interventions to Promote COVID-19 VaccinationsNo drug interventionshealth_services_researchNot Availablecompleted
NCT04801524
Text-based Reminders to Promote COVID-19 VaccinationsNo drug interventionshealth_services_researchNot Availablecompleted
NCT05096260
Getting to Yes, Michigan! (G2YMI)No drug interventionspreventionNot Availableactive_not_recruiting
NCT06199934
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims DataNo drug interventionsNot AvailableNot Availablecompleted
NCT05226390
Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine CandidateNo drug interventionsprevention1terminated
NCT05508477
UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)prevention3unknown_status
NCT05405283
Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adultsprevention3active_not_recruiting
NCT05621928
Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04876885
The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 VaccinationsNo drug interventionsotherNot Availableunknown_status
NCT05298800
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23No drug interventionsprevention4unknown_status
NCT05373459
Effect of a Third COVID-19 Booster Among Health Care WorkersNo drug interventionsNot AvailableNot Availablecompleted
NCT04732819
Improving COVID-19 Vaccine Uptake in Nursing HomesNo drug interventionshealth_services_researchNot Availablecompleted
NCT04881396
Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 VaccineNo drug interventionsNot AvailableNot Availablecompleted
NCT05471635
Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination)No drug interventionsNot AvailableNot Availableunknown_status
NCT04871165
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed IndividualsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05556720
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trialtreatment3recruiting
NCT05406908
Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseasesprevention4completed
NCT04706143
Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in EgyptiansNo drug interventionsNot AvailableNot Availableunknown_status
NCT05012943
The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)No drug interventionsprevention2 / 3completed
NCT06272253
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent SubjectsNo drug interventionsprevention0active_not_recruiting
NCT04888793
Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT06259578
UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)No drug interventionsprevention0recruiting
NCT04895007
Comparative Evaluation of Covid-19 Vaccines ResponseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05924685
PREPARE-iVAC TrialNo drug interventionsprevention4completed
NCT04983537
Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Populationhealth_services_research2unknown_status
NCT04832932
The COVID-19 Back-to-Normal Study: Analysis of Multiple OutcomesNot AvailableNot Availableactive_not_recruiting
NCT05104359
COVID-19 Quantitative Antibody Titers & Booster VaccinationsNo drug interventionsNot AvailableNot Availablecompleted
NCT04962906
Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemeshealth_services_research2completed
NCT05185817
Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant PatientsNo drug interventionsprevention2unknown_status
NCT04751734
Impact of Maternal COVID-19 Vaccines on Breast MilkNo drug interventionsNot AvailableNot Availablecompleted
NCT04852835
Follow-up of COVID-19 Vaccine Response in Strasbourg University HospitalsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05918939
UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)prevention0unknown_status
NCT05571657
COVID-19 Booster Dose Reminder/Recall for AdolescentsNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT05831826
Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05293665
Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccineprevention3active_not_recruiting
NCT06282692
INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years OldNo drug interventionsprevention3recruiting
NCT05027672
Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.health_services_research2unknown_status
NCT05386355
Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth ToolNo drug interventionsotherNot Availablecompleted
NCT05162482
Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)No drug interventionstreatment2unknown_status
NCT05057182
Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)prevention4active_not_recruiting
NCT04659941
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workersprevention2active_not_recruiting
NCT04809948
Effects of COVID 19 Vaccine on Egyptian PopulationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05729191
Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT05079633
A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adultsprevention4completed
NCT05029245
IntraDermal Versus Intramuscular Comirnaty® Efficacy Studyprevention3withdrawn
NCT04695652
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adultprevention2completed
NCT05175742
PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.prevention2completed
NCT05048849
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Studyprevention2completed
NCT05038618
A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-studyprevention2completed
NCT05011526
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adultsprevention3completed
NCT04834869
COVID-19 Vaccines Safety Tracking (CoVaST)Not AvailableNot Availablerecruiting
NCT04730895
Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.prevention1 / 2unknown_status
NCT04951388
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescentsprevention2completed
NCT04765436
PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64No drug interventionsprevention1completed
NCT04822025
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adultsprevention2completed
NCT04818892
Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04760704
Covid-19 Vaccine Response in Elderly SubjectsNo drug interventionsNot AvailableNot Availableunknown_status